Articles From: Agilent Technologies Thought Leader Award Supports Cancer Stem Cell Research at Mount Sinai to AgJunction's Satloc Division Debuts LiteStar III Guidance System for Aerial Application


2014/9/24
Agilent Technologies Inc. (NYSE: A) today announced that Carlos Cordon-Cardo , M.D., Ph.D., of the Mount Sinai Health System, has received an Agilent Thought Leader Award in recognition of his groundbreaking work in molecular and translational pathology.
Sign-up for Agilent Technologies Thought Leader Award Supports Cancer Stem Cell Research at Mount Sinai investment picks
2014/10/14
Agilent Technologies Inc. (NYSE:A) today announced it is exiting its Nuclear Magnetic Resonance business.
Sign-up for Agilent Technologies to Close Nuclear Magnetic Resonance Business investment picks
Agilent Technologies, Inc. (NYSE:A) today announced a collaboration with scientists at the University of Toronto’s Donnelly Centre for Cellular and Biomolecular Research to produce a comprehensive metabolomics multiple-reaction monitoring (MRM) library and methodology, using Agilent’s Infinity 1290 UHPLC and 6460 triple quadrupole mass spectrometry system .
Sign-up for Agilent Technologies to Collaborate with University of Toronto on Metabolomics MRM Library-Software Solution to Accelerate Cell Biology, Disease Research investment picks
2014/10/31
Agilent Technologies Inc. (NYSE:A) will release fourth-quarter fiscal 2014 financial results after the stock market closes on Nov.
Sign-up for Agilent Technologies to Host Webcast of Fourth-Quarter Fiscal Year 2014 Financial Results Conference Call investment picks
Agilysys, Inc. (Nasdaq:AGYS), a leading provider of innovative information technology and hospitality software and services, and B4Checkin, Inc. , a developer and provider of cloud-based hospitality software solutions, today announced a partnership agreement whereby Agilysys will offer the B4Checkin booking engine to its Visual One™ PMS customers.
Sign-up for Agilysys and B4Checkin Partner to Offer Web Booking Engine To Visual One™ PMS Customers investment picks
Agilysys, Inc. (Nasdaq:AGYS), a leading provider of innovative information technology and hospitality software and services, today announced the general availability of InfoGenesis™ POS v4.4.5, the latest version of its award-winning point-of-sale software solution.
Sign-up for Agilysys Announces General Availability of InfoGenesis™ POS v4.4.5 investment picks
Agilysys, Inc. (Nasdaq: AGYS), a leading provider of innovative information technology and hospitality software and services, today announced the general availability of WMx v6.0, the latest version of the Agilysys Workforce Management Solution ™. The new version includes enhanced features and functionality that streamline operations and help ensure compliance with federal regulations.
Sign-up for Agilysys Announces General Availability of WMx v6.0 investment picks
Agilysys, Inc. (Nasdaq:AGYS), a leading provider of innovative information technology and hospitality software and services, today announced an expansion of the rGuest™ product offering to include rGuest Seat, a comprehensive table, reservation and wait list management solution that streamlines operations and enables restaurants to provide superior service.
Sign-up for Agilysys Announces rGuest™ Seat Table Management Solution investment picks
Agilysys, Inc. (Nasdaq:AGYS), a leading provider of innovative information technology and hospitality software and services, today announced the promotion of Rehan Jaddi to senior vice president of customer support & service solutions, effective immediately.
Sign-up for Agilysys Promotes Jaddi to SVP of Customer Support & Service Solutions investment picks
Agilysys, Inc. (Nasdaq: AGYS) , a leading provider of innovative information technology and hospitality software and services, announced today that it will release its fiscal 2015 second quarter results before the market opens on Wednesday, November 5, 2014 and will host a conference call and webcast at 9:00 a.m. ET on Wednesday, November 5.
Sign-up for Agilysys to Report Fiscal 2015 Second Quarter Results on November 5 and Host Conference Call and Webcast investment picks
Agilysys, Inc .
Sign-up for Agilysys Visual One™ PMS Boosts Guest Service at Palm Garden Hotel investment picks
Agilysys, Inc. (Nasdaq: AGYS) , a leading provider of innovative hospitality software solutions and services, today reported operating results for its fiscal 2015 second quarter ended September 30, 2014.
Sign-up for Agilysys’ Fiscal 2015 Second Quarter Revenue Rises 6% to $26.3 Million investment picks
Durable Responses Observed with Patients on Study for up to Eight Months and Ongoing in Advanced Acute Myeloid Leukemia and Other Blood Cancers SAN FRANCISCO, Dec.
Sign-up for Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies investment picks
-Significant Clinical Responses and Reduction of 2HG Biomarker Provide Early Validation of Mutant IDH1 as a Therapeutic Target in AML - CAMBRIDGE, Mass.
Sign-up for Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML) investment picks
Once-Daily Oral Dose Selected From Ongoing Phase 1 Study of AG-221 in Hematologic Malignancies CAMBRIDGE, Mass., Oct.
Sign-up for Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221 investment picks
CAMBRIDGE, Mass., Dec.
Sign-up for Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock investment picks
CAMBRIDGE, Mass., Dec.
Sign-up for Agios Pharmaceuticals Announces Proposed Offering of Common Stock investment picks
CAMBRIDGE, Mass., Dec.
Sign-up for Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results investment picks
CAMBRIDGE, Mass., Sept.
Sign-up for Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease Roundtable investment picks
New Data from Ongoing Phase 1 AG-221 Trial Accepted for Oral Presentation CAMBRIDGE, Mass., Nov.
Sign-up for Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting investment picks
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that clinical data from a Phase 1 study of AG-120, an orally available, selective, potent inhibitor of the mutated IDH1 protein, will be highlighted in a late breaking oral presentation at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place November 18 - 21, 2014, in Barcelona, Spain.
Sign-up for Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014 investment picks
CAMBRIDGE, Mass., Oct.
Sign-up for Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014 investment picks
AG-348 Achieved Proof-of-Mechanism Through Substantial Effects on Two Key Biomarkers of Pyruvate Kinase Activity and Pathway Activation SAN FRANCISCO, Dec.
Sign-up for Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency investment picks
2014/10/2
CLAAS E-Systems KGaA mbH & Co KG will begin factory installation of the S7 and S10 guidance control terminals with GPS Pilot during Q4 2014 at two European factories, integrating key hardware and software technology developed by AgJunction.
Sign-up for AgJunction Precision Platform Selected for OEM Factory Integration investment picks
AgJunction's Satloc Division Debuts LiteStar III Guidance System for Aerial Application Canada NewsWire LOUISVILLE, KY , Dec.
Sign-up for AgJunction's Satloc Division Debuts LiteStar III Guidance System for Aerial Application investment picks
LOUISVILLE, KY , Dec.
Sign-up for AgJunction's Satloc Division Debuts LiteStar III Guidance System for Aerial Application investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Agilent Technologies Thought Leader Award Supports Cancer Stem Cell Research at Mount Sinai to AgJunction's Satloc Division Debuts LiteStar III Guidance System for Aerial Application
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent